Europace

Article	Citations
2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation	484
Multi-national survey on the methods, efficacy, and safety on the post-approval clinical use of pulsed field ablation (MANIFEST-PF)	130
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy	129
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of gen	119
How to use digital devices to detect and manage arrhythmias: an EHRA practical guide	114
Deep learning and the electrocardiogram: review of the current state-of-the-art	113
Cryoballoon ablation vs. antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation	110
Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST)	95
EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators: endorsed by the Heart Rhythm Society (HRS	90
The V6-V1 interpeak interval: a novel criterion for the diagnosis of left bundle branch capture	88
Pulsed field ablation selectively spares the oesophagus during pulmonary vein isolation for atrial fibrillation	85
EHRA clinical consensus statement on conduction system pacing implantation: endorsed by the Asia Pacific Heart Rhythm Society (APHRS), Canadian Heart Rhythm Society (CHRS), and Latin American Heart Rh	84
EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex in collaboration with the ESC Council on valvular heart disease and the European Association	78
Relation of outcomes to ABC (Atrial Fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation: an analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-T	73
‘Hot phase’ clinical presentation in arrhythmogenic cardiomyopathy	69
Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: an insight into the mechanisms of cardiac involvement	67
Standardized pulmonary vein isolation workflow to enclose veins with contiguous lesions: the multicentre VISTAX trial	67
Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference	66
Cardiac resynchronization therapy via left bundle branch pacing vs. optimized biventricular pacing with adaptive algorithm in heart failure with left bundle branch block: a prospective, multi-centre,	66
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac	65
Quality indicators for the care and outcomes of adults with atrial fibrillation	62
High-power short duration vs. conventional radiofrequency ablation of atrial fibrillation: a systematic review and meta-analysis	61
Implementation of an on-demand app-based heart rate and rhythm monitoring infrastructure for the management of atrial fibrillation through teleconsultation: TeleCheck-AF	58
Results of the Patient-Related Outcomes of Mechanical lead Extraction Techniques (PROMET) study: a multicentre retrospective study on advanced mechanical lead extraction techniques	56
Oesophageal Probe Evaluation in Radiofrequency Ablation of Atrial Fibrillation (OPERA): results from a prospective randomized trial	56

Corrigendum to: 2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation	55
The European TeleCheck-AF project on remote app-based management of atrial fibrillation during the COVID-19 pandemic: centre and patient experiences	53
Accuracy of left atrial fibrosis detection with cardiac magnetic resonance: correlation of late gadolinium enhancement with endocardial voltage and conduction velocity	49
Electrocardiographic findings at presentation and clinical outcome in patients with SARS-CoV-2 infection	49
The feasibility and safety of left bundle branch pacing vs. right ventricular pacing after mid-long-term follow-up: a single-centre experience	48
Advanced interatrial block and P-wave duration are associated with atrial fibrillation and stroke in older adults with heart disease: the BAYES registry	46
Randomized comparison of oesophageal protection with a temperature control device: results of the IMPACT study	45
Long-term performance and risk factors analysis after permanent His-bundle pacing and atrioventricular node ablation in patients with atrial fibrillation and heart failure	45
EUropean real-world outcomes with Pulsed field ablatiOn in patients with symptomatic atRIAl fibrillation: lessons from the multi-centre EU-PORIA registry	43
Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions. Part 2: ventricular arrhythmias, chan	42
Supervised Obesity Reduction Trial for AF ablation patients: results from the SORT-AF trial	42
Epidemiology of cardiac implantable electronic device infections: incidence and risk factors	42
Pulsed field ablation prevents chronic atrial fibrotic changes and restrictive mechanics after catheter ablation for atrial fibrillation	41
Local catheter impedance drop during pulmonary vein isolation predicts acute conduction block in patients with paroxysmal atrial fibrillation: initial results of the LOCALIZE clinical trial	40
Association between sodium–glucose cotransporter-2 inhibitors and risk of sudden cardiac death or ventricular arrhythmias: a meta-analysis of randomized controlled trials	40
Mobile health applications for the detection of atrial fibrillation: a systematic review	39
Efficacy and safety of ablation index-guided catheter ablation for atrial fibrillation: an updated meta-analysis	39
Efficacy of high-power and short-duration ablation in patients with atrial fibrillation: a prospective randomized controlled trial	39
Clinical characteristics and risk stratification of desmoplakin cardiomyopathy	39
Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018: a systematic review and meta-analysis	39
Safety of very high-power short-duration radiofrequency ablation for pulmonary vein isolation: a two-centre report with emphasis on silent oesophageal injury	38
Temporal patterns and short-term progression of paroxysmal atrial fibrillation: data from RACE V	38
Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference	37
Combining home monitoring temporal trends from implanted defibrillators and baseline patient risk profile to predict heart failure hospitalizations: results from the SELENE HF study	37
Predictive role of atrial fibrillation in cognitive decline: a systematic review and meta-analysis of 2.8 million individuals	36
Wearables, telemedicine, and artificial intelligence in arrhythmias and heart failure: Proceedings of the European Society of Cardiology Cardiovascular Round Table	36
Management of ventricular electrical storm: a contemporary appraisal	36
Conduction system pacing in everyday clinical practice: EHRA physician survey	36
Risk stratification of patients undergoing transvenous lead extraction with the ELECTRa Registry Outcome Score (EROS): an ESC EHRA EORP European lead extraction ConTRolled ELECTRa registry analysis	36
Association of anticoagulant therapy with risk of dementia among patients with atrial fibrillation	35
Novel left ventricular cardiac synchronization: left ventricular septal pacing or left bundle branch pacing?	35
CarDiac magnEtic Resonance for prophylactic Implantable-cardioVerter defibrillAtor ThErapy in Non-Ischaemic dilated CardioMyopathy: an international Registry	34
Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study	34
Searching for atrial fibrillation: looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper	34
Targeting non-pulmonary vein triggers in persistent atrial fibrillation: results from a prospective, multicentre, observational registry	33
Sex differences in atrial fibrillation ablation outcomes: insights from a large-scale multicentre registry	33
Personalized paroxysmal atrial fibrillation ablation by tailoring ablation index to the left atrial wall thickness: the ‘Ablate by-LAW’ single-centre study—a pilot study	32
Findings from repeat ablation using high-density mapping after pulmonary vein isolation with pulsed field ablation	31
The use of remote monitoring of cardiac implantable devices during the COVID-19 pandemic: an EHRA physician survey	31
Incidence, epidemiology, diagnosis and prognosis of atrio-oesophageal fistula following percutaneous catheter ablation: a French nationwide survey	31
Pulmonary vein isolation alone vs. more extensive ablation with defragmentation and linear ablation of persistent atrial fibrillation: the EARNEST-PVI trial	31
Wearable cardioverter-defibrillator in patients with a transient risk of sudden cardiac death: the WEARIT-France cohort study	31
Implantation technique and optimal subcutaneous defibrillator chest position: a PRAETORIAN score-based study	30
How does the level of pulmonary venous isolation compare between pulsed field ablation and thermal energy ablation (radiofrequency, cryo, or laser)?	30
Cardiac operations and interventions during the COVID-19 pandemic: a nationwide perspective	30
Critical appraisal of technologies to assess electrical activity during atrial fibrillation: a position paper from the European Heart Rhythm Association and European Society of Cardiology Working Grou	30
Reconstruction of three-dimensional biventricular activation based on the 12-lead electrocardiogram via patient-specific modelling	29
EHRA clinical consensus statement on conduction system pacing implantation: executive summary. Endorsed by the Asia-Pacific Heart Rhythm Society (APHRS), Canadian Heart Rhythm Society (CHRS) and Latin	29
Restoration of sinus rhythm by pulmonary vein isolation improves heart failure with preserved ejection fraction in atrial fibrillation patients	29
HRS/EHRA/APHRS/LAHRS/ACC/AHA worldwide practice update for telehealth and arrhythmia monitoring during and after a pandemic	29

Worldwide sedation strategies for atrial fibrillation ablation: current status and evolution over the last decade	29
Radiofrequency ablation: technological trends, challenges, and opportunities	29
Remote monitoring of cardiac implanted electronic devices: legal requirements and ethical principles - ESC Regulatory Affairs Committee/EHRA joint task force report	28
Global burden of atrial fibrillation/atrial flutter and its attributable risk factors from 1990 to 2019	28
Long-term clinical impact of permanent pacemaker implantation in patients undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis	28
Randomized study defining the optimum target interlesion distance in ablation index-guided atrial fibrillation ablation	28
Usefulness of post-procedural heart rate response to predict syncope recurrence or positive head up tilt table testing after cardioneuroablation	28
Current perspectives on wearable rhythm recordings for clinical decision-making: the wEHRAbles 2 survey	28
Development and validation of a risk score for predicting pericardial effusion in patients undergoing leadless pacemaker implantation: experience with the Micra transcatheter pacemaker	27
Optimizing cryoballoon pulmonary vein isolation: lessons from >1000 procedures— the Frankfurt approach	27
Does isolation of the left atrial posterior wall using cryoballoon ablation improve clinical outcomes in patients with persistent atrial fibrillation? A prospective randomized controlled trial	27
Practical considerations, indications, and future perspectives for leadless and extravascular cardiac implantable electronic devices: a position paper by EHRA/HRS/LAHRS/APHRS	27
Brugada syndrome and syncope: a practical approach for diagnosis and treatment	26
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk)	26
Clinical controversy: methodology and indications of cardioneuroablation for reflex syncope	26
EHRA expert consensus document on the management of arrhythmias in frailty syndrome, endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm S	26
Acute and mid-term outcome of ethanol infusion of vein of Marshall for the treatment of perimitral flutter	26
Efficacy and safety of left atrial appendage electrical isolation during catheter ablation of atrial fibrillation: an updated meta-analysis	26
Antiarrhythmic drugs for atrial fibrillation: lessons from the past and opportunities for the future	26
European experience with a first totally leadless cardiac resynchronization therapy pacemaker system	26
Arrhythmic safety of hydroxychloroquine in COVID-19 patients from different clinical settings	25
ESC working group on cardiac cellular electrophysiology position paper: relevance, opportunities, and limitations of experimental models for cardiac electrophysiology research	25
Progressive involvement of cardiac conduction system in paediatric patients with Kearns–Sayre syndrome: how to predict occurrence of complete heart block and sudden cardiac death?	25
The bidirectional interaction between atrial fibrillation and heart failure: consequences for the management of both diseases	25
His bundle pacing capture threshold stability during long-term follow-up and correlation with lead slack	25
Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4 trial	25
Cardiac ablation with pulsed electric fields: principles and biophysics	24
Very high-power short-duration ablation for pulmonary vein isolation utilizing a very-close protocol—the FAST AND FURIOUS PVI study	24
Outcomes in patients with cardiac amyloidosis and implantable cardioverter-defibrillator	24
The Atrial Fibrillation Better Care pathway for managing atrial fibrillation: a review	24
Likelihood of injury due to vasovagal syncope: a systematic review and meta-analysis	24
Relationship between procedural volume and complication rates for catheter ablation of atrial fibrillation: a systematic review and meta-analysis	24
Frequency of injuries associated with syncope in the prevention of syncope trials	23
Screening for atrial fibrillation: predicted sensitivity of short, intermittent electrocardiogram recordings in an asymptomatic at-risk population	23
Exercise restriction is protective for genotype-positive family members of arrhythmogenic right ventricular cardiomyopathy patients	23
Comparison of methods for delivering cardiac resynchronization therapy: an acute electrical and haemodynamic within-patient comparison of left bundle branch area, His bundle, and biventricular pacing	23
Reduction in new cardiac electronic device implantations in Catalonia during COVID-19	23
Investigation on Sudden Unexpected Death in the Young (SUDY) in Europe: results of the European Heart Rhythm Association Survey	23
Risk factor management and atrial fibrillation	23
Conduction system pacing, a European survey: insights from clinical practice	23
Infanticide vs. inherited cardiac arrhythmias	23
Inflammation and adiposity: new frontiers in atrial fibrillation	22
Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five Western European countries	22
First experience with pulsed field ablation as routine treatment for paroxysmal atrial fibrillation	22
Pediatric catheter ablation at the beginning of the 21st century: results from the European Multicenter Pediatric Catheter Ablation Registry ‘EUROPA’	22
Predictive role of early recurrence of atrial fibrillation after cryoballoon ablation	22
Use of healthcare claims to validate the Prevention of Arrhythmia Device Infection Trial cardiac implantable electronic device infection risk score	22
Orthogonal P-wave morphology, conventional P-wave indices, and the risk of atrial fibrillation in the general population using data from the Finnish Hospital Discharge Register	22
The evolution of cardiac resynchronization therapy and an introduction to conduction system pacing: a conceptual review	22
Obstructive sleep apnoea testing and management in atrial fibrillation patients: a joint survey by the European Heart Rhythm Association (EHRA) and the Association of Cardiovascular Nurses and Allied	22
Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: results from a long-term follow-up multicentre study	22
Spotlight on the 2022 ESC guideline management of ventricular arrhythmias and prevention of sudden cardiac death: 10 novel key aspects	22
Anatomical-based percutaneous left stellate ganglion block in patients with drug-refractory electrical storm and structural heart disease: a single-centre case series	22
Infective endocarditis in patients with cardiac implantable electronic devices: a nationwide study	22
Using a smartwatch electrocardiogram to detect abnormalities associated with sudden cardiac arrest in young adults	22
Lead performance and clinical outcomes of patients with permanent His-Purkinje system pacing: a single-centre experience	22
Outcomes after cryoballoon ablation of paroxysmal atrial fibrillation with the PolarX or the Arctic Front Advance Pro: a prospective multicentre experience	22
Current status of reimbursement practices for remote monitoring of cardiac implantable electrical devices across Europe	22
Mobile health applications for managing atrial fibrillation for healthcare professionals and patients: a systematic review	21
Loss-of-function mutations in cardiac ryanodine receptor channel cause various types of arrhythmias including long QT syndrome	21
2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: comment—Authors’ reply	21
Electrocardiographic imaging for cardiac arrhythmias and resynchronization therapy	21
Safety, effectiveness, and quality of life following pulmonary vein isolation with a multi-electrode radiofrequency balloon catheter in paroxysmal atrial fibrillation: 1-year outcomes from SHINE	21
Comparison of various late gadolinium enhancement magnetic resonance imaging methods with high-definition voltage and activation mapping for detection of atrial cardiomyopathy	21
Personalized ablation vs. conventional ablation strategies to terminate atrial fibrillation and prevent recurrence	21
Feasibility and efficacy of left bundle branch area pacing in patients indicated for cardiac resynchronization therapy	21
Development and external validation of prediction models to predict implantable cardioverter-defibrillator efficacy in primary prevention of sudden cardiac death	21
Second-generation laser balloon ablation for the treatment of atrial fibrillation assessed by continuous rhythm monitoring: the LIGHT-AF study	20
Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a European observational multicentre study	20
Predictors of recurrence of atrial fibrillation within the first 3 months after ablation	20
Identification of local atrial conduction heterogeneities using high-density conduction velocity estimation	20
The effect of centre volume and procedure location on major complications and mortality from transvenous lead extraction: an ESC EHRA EORP European Lead Extraction ConTRolled ELECTRa registry subanaly	20
A VIRTUAL Sleep Apnoea management pathway For the work-up of Atrial fibrillation patients in a digital Remote Infrastructure: VIRTUAL-SAFARI	20
Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care	20
Novel cryoballoon ablation system for pulmonary vein isolation: multicenter assessment of efficacy and safety—ANTARCTICA study	20
Prescription of oral anticoagulants and antiplatelets for stroke prophylaxis in atrial fibrillation: nationwide time series ecological analysis	20
Age-related tilt test responses in patients with suspected reflex syncope	20
Catheter ablation improves cardiovascular outcomes in patients with atrial fibrillation and heart failure: a meta-analysis of randomized controlled trials	19
Pulsed field ablation using focal contact force-sensing catheters for treatment of atrial fibrillation: acute and 90-day invasive remapping results	19
Screen-detected atrial fibrillation predicts mortality in elderly subjects	19

Atrial fibrillation burden during the coronavirus disease 2019 pandemic	19
High-degree atrioventricular block in COVID-19 hospitalized patients	19
Watchman FLX vs. Watchman 2.5 in a Dual-Center Left Atrial Appendage Closure Cohort: the WATCH-DUAL study	19
Idiopathic ventricular fibrillation: the ongoing quest for diagnostic refinement	19
Long-term observation of catheter ablation vs. pharmacotherapy in the management of persistent and long-standing persistent atrial fibrillation (CAPA study)	19
Acute oesophageal safety of high-power short duration with 50 W for atrial fibrillation ablation	18
Low-voltage area substrate modification for atrial fibrillation ablation: a systematic review and meta-analysis of clinical trials	18
A unified theory for the circuit of atrioventricular nodal re-entrant tachycardia	18
Early atrial fibrillation detection and the transition to comprehensive management	18
Procedural efficiencies, lesion metrics, and 12-month clinical outcomes for Ablation Index-guided 50 W ablation for atrial fibrillation	18
Right ventricular epicardial arrhythmogenic substrate in long-QT syndrome patients at risk of sudden death	18
Midodrine for the prevention of vasovagal syncope: a systematic review and meta-analysis	18
Prediction of occult atrial fibrillation in patients after cryptogenic stroke and transient ischaemic attack: PROACTIA	18
Diagnostic yield and accuracy in a tertiary referral syncope unit validating the ESC guideline on syncope: a prospective cohort study	18
Smartphone electrocardiogram for detecting atrial fibrillation after a cerebral ischaemic event: a multicentre randomized controlled trial	18
The use of social media for professional purposes by healthcare professionals: the #intEHRAct survey	18
Electrocardiographic predictors of infrahissian conduction disturbances in myotonic dystrophy type 1	18
Ventricular arrhythmias in arrhythmic mitral valve syndrome—a prospective continuous long-term cardiac monitoring study	17
Magnetic resonance assessment of left atrial scar formation following a novel very high-power short-duration workflow for atrial fibrillation ablation	17
Twitter for professional use in electrophysiology: practical guide for #EPeeps	17
A meta-analysis of clinical risk factors for stroke in anticoagulant-naïve patients with atrial fibrillation	17
Plasma adenosine and neurally mediated syncope: ready for clinical use	17
Increased beat-to-beat variability of cerebral microcirculatory perfusion during atrial fibrillation: a near-infrared spectroscopy study	17
Self-reported treatment burden in patients with atrial fibrillation: quantification, major determinants, and implications for integrated holistic management of the arrhythmia	17
Remote monitoring data from cardiac implantable electronic devices predicts all-cause mortality	17
Initial and long-term antithrombotic therapy after left atrial appendage closure with the WATCHMAN	17
Pulmonary vein isolation with the radiofrequency balloon catheter: a single centre prospective study	17
Bipolar ablation of therapy-refractory ventricular arrhythmias: application of a dedicated approach	17
Acute safety, efficacy, and advantages of a novel cryoballoon ablation system for pulmonary vein isolation in patients with paroxysmal atrial fibrillation: initial clinical experience	17
STereotactic Arrhythmia Radioablation (STAR): the Standardized Treatment and Outcome Platform for Stereotactic Therapy Of Re-entrant tachycardia by a Multidisciplinary consortium (STOPSTORM.eu) and re	17
Causes, circumstances, and potential preventability of cardiac arrest in the young: insights from a state-wide clinical and forensic registry	17
Focal Impulse and Rotor Modulation Ablation vs. Pulmonary Vein isolation for the treatment of paroxysmal Atrial Fibrillation: results from the FIRMAP AF study	17
Miniseries 1—Part III: ‘Behind the scenes’ in the triangle of Koch	17
Evidence-based insights on ideal blanking period duration following atrial fibrillation catheter ablation	17
Higher power short duration vs. lower power longer duration posterior wall ablation for atrial fibrillation and oesophageal injury outcomes: a prospective multi-centre randomized controlled study (Hi-	17
Clinical outcomes and programming strategies of implantable cardioverter-defibrillator devices in paediatric hypertrophic cardiomyopathy: a UK National Cohort Study	17
Effect of remote monitoring on clinical outcomes in European heart failure patients with an implantable cardioverter-defibrillator: secondary results of the REMOTE-CIED randomized trial	17
The GermAn Laser Lead Extraction RegistrY: GALLERY	17
Incidence and predictors of sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy: a pooled analysis	16
Dantrolene reduces CaMKIIδC-mediated atrial arrhythmias	16
Catheter ablation for non-paroxysmal atrial fibrillation accompanied by heart failure with preserved ejection fraction: feasibility and benefits in functions and B-type natriuretic peptide	16
Budget impact analysis of a machine learning algorithm to predict high risk of atrial fibrillation among primary care patients	16
Cardiovascular magnetic resonance determinants of ventricular arrhythmic events after myocardial infarction	16
Sinus rhythm voltage fingerprinting in patients with mitral valve disease using a high-density epicardial mapping approach	16
Prevalence of asystole during tilt test-induced vasovagal syncope may depend on test methodology	16
Single shot electroporation of premature ventricular contractions from the right ventricular outflow tract	16
Long-term outcomes in a randomized controlled trial of multimodality imaging-guided left ventricular lead placement in cardiac resynchronization therapy	16
Perceived vs. objective frailty in patients with atrial fibrillation and impact on anticoagulant dosing: an ETNA-AF-Europe sub-analysis	16
New-onset atrial fibrillation following left bundle branch area pacing vs. right ventricular pacing: a two-centre prospective cohort study	16
The digital journey: 25 years of digital development in electrophysiology from an Europace perspective	16
Diagnostic yield and financial implications of a nationwide electrocardiographic screening programme to detect cardiac disease in the young	16
Prevention of cardiac implantable electronic device infections: guidelines and conventional prophylaxis	16
Mortality and cardiac resynchronization therapy with or without defibrillation in primary prevention	16
Human biventricular electromechanical simulations on the progression of electrocardiographic and mechanical abnormalities in post-myocardial infarction	16
Long-term prognosis of patients undergoing radiofrequency catheter ablation for atrial fibrillation: comparison between heart failure subtypes based on left ventricular ejection fraction	16
The blanking period after atrial fibrillation ablation: an European Heart Rhythm Association survey on contemporary definition and management	16
Accuracy of electroanatomical mapping-guided cardiac radiotherapy for ventricular tachycardia: pitfalls and solutions	16
Magnetic resonance-guided re-ablation for atrial fibrillation is associated with a lower recurrence rate: a case–control study	15
Prediction of thromboembolic events and mortality by the CHADS2 and the CHA2DS2-VASc in COVID-19	15
A randomized study of yoga therapy for the prevention of recurrent reflex vasovagal syncope	15
2023 HRS/EHRA/APHRS/LAHRS Expert Consensus Statement on Practical Management of the Remote Device Clinic	15
Risk of ventricular arrhythmia in cardiac resynchronization therapy responders and super-responders: a systematic review and meta-analysis	15
Reimbursement practices for use of digital devices in atrial fibrillation and other arrhythmias: a European Heart Rhythm Association survey	15
European Society of Cardiology Quality Indicators for the care and outcomes of cardiac pacing: developed by the Working Group for Cardiac Pacing Quality Indicators in collaboration with the European H	15
Cryoballoon vs. radiofrequency catheter ablation: insights from NOrwegian randomized study of PERSistent Atrial Fibrillation (NO-PERSAF study)	15
Machine learning in sudden cardiac death risk prediction: a systematic review	15
Atrial fibrillation progression and the importance of early treatment for improving clinical outcomes	15
C-reactive protein after coronary artery bypass graft surgery and its relationship with postoperative atrial fibrillation	15
Ventricular arrhythmia risk is associated with myocardial scar but not with response to cardiac resynchronization therapy	15
Management of ventricular tachycardia in patients with ischaemic cardiomyopathy: contemporary armamentarium	15
The SIDECAR project: S-IcD registry in European paediatriC and young Adult patients with congenital heaRt defects	15
Catheter ablation vs. antiarrhythmic drugs as ‘first-line’ initial therapy for atrial fibrillation: a pooled analysis of randomized data	15
Enrichment of loss-of-function and copy number variants in ventricular cardiomyopathy genes in ‘lone’ atrial fibrillation	15
Left atrial fibrosis predicts left ventricular ejection fraction response after atrial fibrillation ablation in heart failure patients: the Fibrosis-HF Study	15
Atrial fibrillation burden: an update—the need for a CHA2DS2-VASc-AFBurden score	15
Prediction of low-voltage areas using modified APPLE score	15
Avoiding implant complications in cardiac implantable electronic devices: what works?	15
Validation of a multipolar pulsed-field ablation catheter for endpoint assessment in pulmonary vein isolation procedures	15
Leadless pacemaker implantation quality: importance of the operator’s experience	15
Knowledge gaps, lack of confidence, and system barriers to guideline implementation among European physicians managing patients with CIED lead or infection complications: a European Heart Rhythm Assoc	15
Safety and efficacy of intracardiac echocardiography–guided zero-fluoroscopic cryoballoon ablation for atrial fibrillation: a prospective randomized controlled trial	15
Sleep apnoea has a dose-dependent effect on atrial remodelling in paroxysmal but not persistent atrial fibrillation: a high-density mapping study	15
Effect of alcohol consumption on the risk of adverse events in atrial fibrillation: from the COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF)	15
Adopting permanent His bundle pacing: learning curves and medium-term outcomes	15
Prospective use of ablation index for the ablation of right ventricle outflow tract premature ventricular contractions: a proof of concept study	14
Comprehensive comparison of stroke risk score performance: a systematic review and meta-analysis among 6 267 728 patients with atrial fibrillation	14
Non-invasive stereotactic arrhythmia radiotherapy for ventricular tachycardia: results of the prospective STARNL-1 trial	14
Epicardial adipose tissue modulates arrhythmogenesis in right ventricle outflow tract cardiomyocytes	14
Infections associated with cardiac electronic implantable devices: economic perspectives and impact of the TYRX™ antibacterial envelope	14
AFA-Recur: an ESC EORP AFA-LT registry machine-learning web calculator predicting atrial fibrillation recurrence after ablation	14
Efficacy and safety of same-day discharge after atrial fibrillation ablation compared with post-procedural overnight stay: a systematic review and meta-analysis	14
Progress in atrial fibrillation ablation during 25 years of Europace journal	14
Long-term impact of the burden of new-onset atrial fibrillation in patients with acute myocardial infarction: results from the NOAFCAMI-SH registry	14
Life-threatening arrhythmias with autosomal recessive TECRL variants	14
Influence of atrial fibrillation type on outcomes of ablation vs. drug therapy: results from CABANA	14